Axon Enterprise (NASDAQ:AXON) Given Outperform Rating at William Blair

William Blair reiterated their outperform rating on shares of Axon Enterprise (NASDAQ:AXONFree Report) in a research report sent to investors on Wednesday, RTT News reports.

Other equities analysts also recently issued reports about the stock. JMP Securities lifted their price target on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a market outperform rating in a report on Tuesday, February 6th. JPMorgan Chase & Co. lifted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an overweight rating in a report on Thursday, April 11th. Barclays boosted their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an overweight rating in a research note on Thursday, February 29th. TheStreet downgraded shares of Axon Enterprise from a b rating to a c+ rating in a research note on Tuesday, February 27th. Finally, Morgan Stanley boosted their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock an equal weight rating in a research note on Wednesday, February 28th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus target price of $312.64.

View Our Latest Report on AXON

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $302.41 on Wednesday. Axon Enterprise has a twelve month low of $175.37 and a twelve month high of $329.87. The firm has a market cap of $22.82 billion, a P/E ratio of 131.48 and a beta of 0.93. The firm’s 50-day simple moving average is $302.15 and its 200-day simple moving average is $260.29. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. As a group, research analysts expect that Axon Enterprise will post 2.44 EPS for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

A number of institutional investors and hedge funds have recently modified their holdings of the business. Brookstone Capital Management raised its stake in shares of Axon Enterprise by 5.1% during the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock worth $263,000 after buying an additional 41 shares during the last quarter. HB Wealth Management LLC raised its stake in shares of Axon Enterprise by 3.9% during the fourth quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock worth $294,000 after buying an additional 43 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its stake in shares of Axon Enterprise by 1.1% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock worth $1,033,000 after buying an additional 43 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Axon Enterprise by 11.0% during the fourth quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after buying an additional 44 shares during the last quarter. Finally, CWM LLC raised its stake in shares of Axon Enterprise by 1.8% during the third quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock worth $531,000 after buying an additional 46 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.